Arax Advisory Partners’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.38M | Buy |
6,000
+5,943
| +10,426% | +$1.69M | 0.02% | 772 |
|
|
2026
Q1 | $9.88K | Sell |
57
-756
| -93% | -$155K | ﹤0.01% | 2444 |
|
|
2025
Q4 | $208K | Sell |
813
-26,677
| -97% | -$6.99M | 0.01% | 1024 |
|
|
2025
Q3 | $7.15M | Buy |
27,490
+27,335
| +17,635% | +$7.19M | 0.1% | 160 |
|
|
2025
Q2 | $58.7K | Buy |
155
+37
| +31% | +$9.22K | ﹤0.01% | 1158 |
|
|
2025
Q1 | $31.2K | Buy |
118
+33
| +39% | +$8.93K | ﹤0.01% | 1122 |
|
|
2024
Q4 | $21.6K | Sell |
85
-25
| -23% | -$6.71K | ﹤0.01% | 1183 |
|
|
2024
Q3 | $34.8K | Buy |
110
+21
| +24% | +$7.47K | ﹤0.01% | 858 |
|
|
2024
Q2 | $33.3K | Buy |
+89
| New | +$30K | ﹤0.01% | 797 |
|
|
2024
Q1 | – | Sell |
-3
| Closed | -$1.37K | – | 1349 |
|
|
2023
Q4 | $1.37K | Hold |
3
| – | – | ﹤0.01% | 1072 |
|
|
2023
Q3 | $1.46K | Hold |
3
| – | – | ﹤0.01% | 1063 |
|
|
2023
Q2 | $1.34K | Hold |
3
| – | – | ﹤0.01% | 1054 |
|
|
2023
Q1 | $1.46K | Hold |
3
| – | – | ﹤0.01% | 1038 |
|
|
2022
Q4 | $1.54K | Hold |
3
| – | – | ﹤0.01% | 982 |
|
|
2022
Q3 | $1K | Sell |
3
-22
| -88% | -$10.7K | ﹤0.01% | 1090 |
|
|
2022
Q2 | $12K | Buy |
+25
| New | +$11.1K | ﹤0.01% | 628 |
|
|
2020
Q4 | $31K | Buy |
76
+58
| +322% | +$24.1K | ﹤0.01% | 457 |
|
|
2020
Q3 | $7K | Sell |
18
-374
| -95% | -$150K | ﹤0.01% | 578 |
|
|
2020
Q2 | $152K | Hold |
392
| – | – | 0.03% | 199 |
|
|
2020
Q1 | $123K | Hold |
392
| – | – | 0.03% | 202 |
|
|
2019
Q4 | $144K | Hold |
392
| – | – | 0.04% | 205 |
|
|
2019
Q3 | $100K | Buy |
392
+18
| +5% | +$5.05K | 0.03% | 244 |
|
|
2019
Q2 | $99K | Buy |
+374
| New | +$94.8K | 0.03% | 234 |
|
|
2018
Q4 | $107K | Buy |
374
+242
| +183% | +$76.7K | 0.04% | 175 |
|
|
2018
Q3 | $45K | Buy |
132
+25
| +23% | +$8.12K | 0.02% | 297 |
|
|
2018
Q2 | $31K | Buy |
107
+6
| +6% | +$1.76K | 0.01% | 263 |
|
|
2018
Q1 | $27K | Buy |
101
+5
| +5% | +$1.35K | 0.01% | 258 |
|
|
2017
Q4 | $23K | Hold |
96
| – | – | 0.01% | 270 |
|
|
2017
Q3 | $23K | Buy |
96
+3
| +3% | +$735 | 0.01% | 265 |
|
|
2017
Q2 | $22K | Buy |
93
+60
| +182% | +$13.6K | 0.01% | 291 |
|
|
2017
Q1 | $6K | Buy |
33
+4
| +14% | +$827 | ﹤0.01% | 349 |
|
|
2016
Q4 | $6K | Buy |
+29
| New | +$5.53K | ﹤0.01% | 347 |
|
Other funds holding HUM
SC
Arax Advisory Partners's HUM Position: Q2 2026 in Review
Arax Advisory Partners increased its Humana (HUM) stake by 10,426% in Q2 2026, buying an estimated $1.69M and bringing the position to 6,000 shares worth $2.38M. The position accounts for 0.02% of the portfolio, ranked #772.
Arax Advisory Partners first reported a position in HUM in Q4 2016 and has held it in 32 quarters since. The position peaked at $7.15M in Q3 2025. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.
- Arax Advisory Partners held 6,000 shares of Humana worth $2.38M as of Q2 2026.
- Arax Advisory Partners bought 5,943 Humana shares in Q2 2026, an estimated $1.69M.
- Humana made up 0.02% of Arax Advisory Partners's portfolio in Q2 2026, its #772 holding.
- Arax Advisory Partners first reported a position in Humana in Q4 2016 and has held it in 32 quarters since.
- Arax Advisory Partners's Humana position peaked at $7.15M in Q3 2025.
- 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.